Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-09 Purchase |
2022-08-11 4:08 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
115,000 | $7.5457 | $867,750 | 11,350,085 (Indirect) |
View |
| 2022-08-08 Purchase |
2022-08-10 4:10 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
97,000 | $7.24 | $702,280 | 11,235,085 (Indirect) |
View |
| 2022-08-05 Purchase |
2022-08-09 4:08 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
141,000 | $6.95 | $979,950 | 11,138,085 (Indirect) |
View |
| 2022-08-04 Purchase |
2022-08-08 4:09 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
95,100 | $6.17 | $586,767 | 10,997,085 (Indirect) |
View |
| 2022-08-03 Purchase |
2022-08-05 4:10 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
100,000 | $5.84 | $584,000 | 10,901,985 (Indirect) |
View |
| 2022-08-02 Purchase |
2022-08-04 4:10 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
412,406 | $5.59 | $2,305,350 | 10,801,985 (Indirect) |
View |
| 2022-08-01 Purchase |
2022-08-03 5:16 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
144,185 | $5.05 | $728,134 | 10,389,579 (Indirect) |
View |
| 2022-07-29 Purchase |
2022-08-02 4:27 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
222,123 | $5.03 | $1,117,279 | 10,245,394 (Indirect) |
View |
| 2022-07-28 Purchase |
2022-08-01 5:37 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
119,392 | $5 | $596,960 | 10,023,271 (Indirect) |
View |
| 2022-06-23 Purchase |
2022-06-27 06:42 am |
Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director |
4,323 | $3.4755 | $15,025 | 23,967 (Direct) |
View |
| 2022-06-23 Purchase |
2022-06-27 06:41 am |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
17,700 | $3.3642 | $59,546 | 1,216,535 (Direct) |
View |
| 2021-05-03 Purchase |
2021-05-04 5:55 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,200,000 | $12.5 | $15,000,000 | 9,903,879 (Indirect) |
View |
| 2021-01-19 Purchase |
2021-01-21 5:24 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,368,421 | $9.5 | $13,000,000 | 8,703,879 (Indirect) |
View |
| 2021-01-07 Purchase |
2021-01-11 9:53 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
1,050,000 | $8.7644 | $9,202,668 | 7,335,458 (Indirect) |
View |
| 2020-07-09 Purchase |
2020-07-13 4:30 pm |
Aldeyra Therapeutics Inc. | ALDX | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH 10% Owner |
3,200,000 | $4.25 | $13,600,000 | 6,285,458 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-28 Option Award |
2023-03-02 4:25 pm |
N/A 2033-02-27 |
Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks |
110,028 | $0 | 110,028 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-02 4:22 pm |
N/A 2033-02-27 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
488,750 | $0 | 1,705,285 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:34 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
604,308 | $0 | 604,308 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:34 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks |
126,087 | $0 | 133,900 (Direct) |
View |
| 2022-07-15 Option Award |
2022-07-19 4:34 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
255,078 | $0 | 342,947 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:07 pm |
N/A 2032-06-06 |
Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director |
62,394 | $0 | 62,394 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:07 pm |
N/A 2032-06-06 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
56,131 | $0 | 56,131 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:06 pm |
N/A 2032-06-06 |
Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director |
61,930 | $0 | 61,930 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:06 pm |
N/A 2032-06-06 |
Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director |
61,002 | $0 | 61,002 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:06 pm |
N/A 2032-06-06 |
Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director |
69,353 | $0 | 69,353 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-09 5:04 pm |
N/A 2032-06-06 |
Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director |
56,131 | $0 | 56,131 (Direct) |
View |
Ownership |
2022-05-13 4:28 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Greenberg Bruce See Remarks |
0 | $0 | 333,685 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 7:44 pm |
N/A 2032-03-29 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
457,758 | $0 | 1,656,593 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 7:37 pm |
N/A 2032-03-29 |
Aldeyra Therapeutics Inc. | ALDX | Reed Joshua Chief Financial Officer |
343,322 | $0 | 524,825 (Direct) |
View |
| 2022-03-30 Option Award |
2022-04-01 7:37 pm |
N/A 2032-03-29 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
314,395 | $0 | 337,869 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:46 pm |
N/A 2031-06-07 |
Aldeyra Therapeutics Inc. | ALDX | DOUGLAS RICHARD Director |
17,442 | $0 | 17,442 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:46 pm |
N/A 2031-06-07 |
Aldeyra Therapeutics Inc. | ALDX | Phillips Gary M. Director |
15,576 | $0 | 15,576 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:46 pm |
N/A 2031-06-07 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
14,117 | $0 | 14,117 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:45 pm |
N/A 2031-06-07 |
Aldeyra Therapeutics Inc. | ALDX | JOYCE MARTIN JOSEPH Director |
15,692 | $0 | 15,692 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:45 pm |
N/A 2031-06-07 |
Aldeyra Therapeutics Inc. | ALDX | Walker Neal Director |
14,117 | $0 | 14,117 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:44 pm |
N/A 2031-06-07 |
Aldeyra Therapeutics Inc. | ALDX | Bronstein Ben Director |
15,342 | $0 | 15,342 (Direct) |
View |
| 2021-04-12 Option Award |
2021-04-14 7:25 pm |
N/A 2031-04-11 |
Aldeyra Therapeutics Inc. | ALDX | Reed Joshua Chief Financial Officer |
150,185 | $0 | 150,185 (Direct) |
View |
| 2021-04-12 Option Award |
2021-04-14 7:24 pm |
N/A 2031-04-11 |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
116,201 | $0 | 116,201 (Direct) |
View |
| 2021-04-12 Option Award |
2021-04-14 7:23 pm |
N/A 2031-04-11 |
Aldeyra Therapeutics Inc. | ALDX | Brady Todd C President and CEO |
296,619 | $0 | 1,198,835 (Direct) |
View |
Ownership |
2020-12-18 6:06 pm |
N/A N/A |
Aldeyra Therapeutics Inc. | ALDX | Machatha Stephen Chief Development Officer |
0 | $0 | 325,635 (Direct) |
View |